SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBridgepoint Regulatory News (BPT)

Share Price Information for Bridgepoint (BPT)

Share Price is delayed by 15 minutes
Get Live Data
244.40    5.60 (2.35%)
Bid:
244.60
Ask:
245.00
Spread: 0.40 (0.164%)
Market Cap: £2.14b
BPT Live PriceLast checked at - London Stock Exchange

Intraday Bridgepoint Share Chart

Update on ECP Transaction Timetable

4 Mar 2024 07:00

RNS Number : 3662F
Bridgepoint Group plc
04 March 2024
Β 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

Β 

Bridgepoint Group plc

("Bridgepoint" or the "Company")

Update on Transaction Timetable

Further to Bridgepoint's announcement on 6 September 2023 regarding the agreement to add Energy Capital Partners Holdings, LP and its affiliated entities to the platform (the "Transaction") (and additional announcements on 2 October 2023 and 20 October 2023), Bridgepoint confirms that all relevant regulatory clearances have now been received for the Transaction, save for a clearance applied for by ECP ControlCo, LLC from the Federal Energy Regulatory Commission ("FERC").

On 1 March, FERC issued an order where it did not grant the authorisation sought on the basis that insufficient information had been provided with respect to proposed voting restrictions agreed to by one of Bridgepoint's minority shareholders to limit their indirect control over certain FERC regulated entities. The FERC order expressly provides that it is without prejudice to ECP ControlCo, LLC's ability to submit a new filing providing additional information addressing the points raised, and it is intended that such an application will be made in the coming days. To simplify the process for the new application, Bridgepoint is also working with the relevant shareholder to address the points raised in the FERC order. Any arrangements entered into by such shareholder will not have any impact on the underlying terms of the Transaction.

However, as a result of the requirement to re-file the FERC application, Bridgepoint now expects Closing to occur during the second quarter of 2024.

Capitalised terms not otherwise defined in this announcement have the meaning given to them in the circular published on 2 October 2023.

ENQUIRIES:

Bridgepoint

Β 

Analysts and investors

Adam Key

adam.key@bridgepoint.eu

+44 7833 748010

Media

Christian Jones / James Murray

christian.jones@bridgepoint.eu

james.murray@bridgepoint.eu

+44 20 7034 3500

FGS Global (Public Relations Adviser to Bridgepoint)

Charles O'Brien / +44 20 7251 3801 / +44 7825 043 656

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

bridgepoint@fgsglobal.com

Legal Entity IdentifierΒ (LEI): 213800KFNMVI8PDZX472

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDQKNBKCBKDCNK
Date   Source Headline
9th Jun 20267:00 amRNSHolding(s) in Company
12th May 20264:15 pmRNSResult of AGM
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTotal Voting Rights
26th Mar 202610:00 amRNSAnnual Report and Accounts and Notice of AGM
23rd Mar 202610:45 amRNSIssue of Equity and Total Voting Rights
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 202612:30 pmRNSIssue of Equity and Total Voting Rights
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 202611:30 amRNSIssue of Equity
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.